retatrutide peptide vs tirzepatide Tirzepatide: GLP-1, GIP & Glucagon Retatrutide vs Tirzepatide: Triple Agonist

Both medications carry a lower risk of causing hypoglycemia compared to other diabetes treatments

If you experience any suspected side effects from your medications, report them through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app)

Mounjaro injections for obesity contain Tirzepatide, a groundbreaking medication that targets both GLP-1 and GIP receptors to reduce appetite, regulate blood sugar, and promote significant weight loss

If you are on a long-term program, your provider may want to run regular blood tests to check your liver enzymes

Semaglutide was on the FDA shortage list during 20222024, which expanded compounding

Pharmaceuticals (Basel) 17(7):970